| 注册
首页|期刊导航|世界中医药|华蟾素联合肝动脉化疗栓塞治疗原发性肝癌的疗效与安全性Meta分析

华蟾素联合肝动脉化疗栓塞治疗原发性肝癌的疗效与安全性Meta分析

田怀平 高蕙敏 杨萍 唐跃年

世界中医药2016,Vol.11Issue(10):2151-2155,5.
世界中医药2016,Vol.11Issue(10):2151-2155,5.DOI:10.3969/j.issn.1673-7202.2016.10.058

华蟾素联合肝动脉化疗栓塞治疗原发性肝癌的疗效与安全性Meta分析

Meta-analysis on Efficacy and Safety of Cinobufacini Combined with Transcatheter Arterial Chemoembolization for Primary Liver Cancer

田怀平 1高蕙敏 1杨萍 1唐跃年1

作者信息

  • 1. 上海交通大学医学院附属新华医院,上海,200092
  • 折叠

摘要

Abstract

Objective: To assess the efficacy and safety of cinobufacini combined with transcatheter arterial chemoembolization (TACE) on patients with primary liver cancer by Meta-analysis.Methods:Databases, such as PubMed, The Cochrane Library, EMbase, VIP, WanFang Data, CBM and CNKI from to October, 2015 were searched for clinical trials on cinobufacini combined with transcatheter arterial chemoembolization for primary liver cancer .Two reviewers independently screened literature according to the inclusion and exclusion criteria , extracted data , and assessed methodological quality .Meta-analysis was performed by RevMan 5.2.Results:Nineteen trials were included with a total of 1481 patients.The results of meta-analysis showed that the treatment group was superior to the TACE group in terms of short-term efficacy and long-term efficacy, improving the quality of life and cau-sing less adverse reaction partly .Conclusion: Cinobufacini combined with TACE are comparatively more efficient and safer for primary liver cancer .

关键词

肝癌/原发性肝癌/华蟾素/肝动脉化疗栓塞/Meta分析

Key words

Liver cancer/Hepatocellular carcinoma/Cinobufacini/Huachansu/Transcatheter arterial chemoembolization/Me-ta-analysis

分类

医药卫生

引用本文复制引用

田怀平,高蕙敏,杨萍,唐跃年..华蟾素联合肝动脉化疗栓塞治疗原发性肝癌的疗效与安全性Meta分析[J].世界中医药,2016,11(10):2151-2155,5.

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文